GENE FOR PREDICTING THE PROGNOSIS FOR EARLY-STAGE BREAST CANCER, AND A METHOD FOR PREDICTING THE PROGNOSIS FOR EARLY-STAGE BREAST CANCER BY USING THE SAME
    1.
    发明申请
    GENE FOR PREDICTING THE PROGNOSIS FOR EARLY-STAGE BREAST CANCER, AND A METHOD FOR PREDICTING THE PROGNOSIS FOR EARLY-STAGE BREAST CANCER BY USING THE SAME 审中-公开
    用于预测早期乳腺癌预后的基因,以及通过使用该方法预测早期乳腺癌的预后的方法

    公开(公告)号:US20130344482A1

    公开(公告)日:2013-12-26

    申请号:US13935502

    申请日:2013-07-04

    Applicant: Gencurix Inc.

    Abstract: The present invention relates to a method for selecting a gene intended to predict the prognosis for a cancer, to the selected gene for predicting the prognosis of cancer and to a kit for predicting and a method for predicting metastasis in breast-cancer patients by using the same. In the present invention, a straight forward method is used to achieve high-reliability prediction of the patient's prognosis by analysing for the genetic characteristics of early stage breast cancer, and thus the present invention can be used to advantage in prognosis diagnosis which can reduce unnecessary anticancer therapy.

    Abstract translation: 本发明涉及选择用于预测癌症预后的基因的方法,所选择的用于预测癌症预后的基因和用于预测的试剂盒和用于预测乳腺癌患者转移的方法的方法,所述方法通过使用 相同。 在本发明中,通过分析早期乳腺癌的遗传特征,使用直接法来实现患者预后的高可靠性预测,因此本发明可以用于预后诊断中,可以减少不必要的 抗癌治疗。

Patent Agency Ranking